Oriola-KD's pro forma review 1 January - 30 September 2006

Oriola-KD Corporation stock exchange release 1 November 2006 at 8.30am

Oriola-KD's pro forma review 1 January - 30 September 2006

Oriola-KD Corporation was listed on the Helsinki Exchanges on 3 July 2006. This
pro forma review presents Oriola-KD Corporation's (Oriola-KD) figures for
January-September 2006 according to the businesses and corporate structure
following the demerger of Orion Corporation. The comparison figures from 2005
are based on published figures for Orion Corporation's Wholesale and
Distribution Division extracted from financial data for Orion Corporation,
which have been adapted to correspond to the businesses and structure
subsequent to demerger. The figures for Oriola-KD's period under review have
been prepared in accordance with the recognition and valuation principles of
the IFRS standards and the figures are unaudited. Oriola-KD Corporation
published its interim report for July-September on 1 November 2006. 

Key figures

- Invoicing in the period was EUR 1,737.1 million (1-9/2005: EUR 1,773.0
million) and net sales were EUR 991.0 million (1-9/2005: EUR 983.8 million). 
- Operating profit excluding one-off items was EUR 17.1 million (1-9/2005: EUR
19.1 million). 
- Operating profit including one-off items was EUR 12.1 million (1-9/2005: EUR
19.1 million). 
- Cash flow from operations was EUR 28.3 million (1-9/2005: EUR 17.8 million).
- Return on capital employed (ROCE) was 8.1 per cent (1-9/2005 12.2 per cent).
- Earnings per share were EUR 0.06 (1-9/2005: EUR 0.08).

President and CEO Eero Hautaniemi: "Oriola-KD's operating profit for the first
three quarters of 2006 was lower than the comparable operating profit in 2005
mainly due to the heavy competitive situation and slow growth of the
pharmaceutical market in Finland as well as to the one-off items related to the
demerger and the operational rearrangements being implemented in Oriola-KD.
Cost efficiency measures at Oriola-KD together with our strong cash flow and
balance sheet and further combined with favourable long-term fundamentals in
the healthcare market will allow positive development in our future business
performance." 

Future outlook

Oriola-KD's outlook for 2006 is based on external market forecasts, agreements
with principals, cumulative orders and management's estimates. 

Finnish pharmaceutical market growth is estimated to be flat in 2006. Swedish
pharmaceutical market is estimated to grow by 4-5 per cent in 2006. Long term
fundamentals and growth prospects are deemed favourable. Oriola-KD estimates
that the longer term pharmaceutical market will grow by about 3-5 per cent in
Finland and Sweden over the next few years, which is in line with the average
growth rate of these markets. 

The overall objective of the cost efficiency measures that were launched in the
early part of 2006 is to achieve total savings of some five million euros
annually in the Group's operations in Finland and Sweden, with full impact as
of 2007. The one-off items of the cost efficiency measures are estimated to be
about EUR 3 million and they will occur in 2006. 

Oriola-KD estimates that the market for healthcare and dental equipment and
supplies will grow by more than 5 per cent in Finland and Sweden in 2006. In
sales of healthcare equipment and supplies, Oriola-KD estimates that its growth
will outpace that of the market. The dental trade is expected to grow at a rate
slower than market growth. Invoicing for the healthcare logistics services in
Sweden is estimated to be at the previous year's level. 

Oriola-KD's invoicing in 2006 is forecast to be nearly at the level of the
previous year's comparable invoicing. Operating profit for 2006 is forecast to
be lower than the previous year's comparable operating profit, owing mainly to
the tight competitive situation within pharmaceutical distribution and trade
and the slow growth in Finland's pharmaceutical market in the early part of the
year as well as one-off expenses for the demerger and the reorganisation of
functions. 


Espoo, 1 November 2006

Oriola-KD Corporation's Board of Directors

Oriola-KD Corporation

Eero Hautaniemi
President and CEO

Kimmo Virtanen
CFO

For additional information, contact:

Eero Hautaniemi
President and CEO
tel. +358 10 429 2109
email: eero.hautaniemi@oriola-kd.com

Kimmo Virtanen
CFO
tel. +358 10 429 2069
email: kimmo.virtanen@oriola-kd.com


Pellervo Hämäläinen
Vice President, Communications and IR
tel. +358 10 429 2497
email: pellervo.hamalainen@oriola-kd.com

Distribution
Helsinki Stock Exchange
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Harmaaparrankuja 1
FI-02200 Espoo
www.oriola-kd.com

The full report including tables can be downloaded from the following link:

Oriola-KD's pro forma review 1 January - 30 September 2006

Presentation 1 November 2006 downloaded from the following link:

Oriola-KD's Pro Forma January-September 2006